Publications by authors named "Patrick Flume"

Claim this Profile
E
European Respiratory Society clinical practice guideline for the management of adult bronchiectasis.
James D Chalmers, Charles S Haworth, Patrick Flume, Merete B Long, Pierre-Régis Burgel

Eur Respir J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlates of FEV₁ deficit in pulmonary exacerbations of cystic fibrosis and associated clinical outcomes.
Oliver J McElvaney, Sonya L Heltshe, Don B Sanders, Natalie E West, Barbra Fogarty, Patrick A Flume

J Cyst Fibros· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the association of antibiotic spectrum and treatment responses of cystic fibrosis pulmonary exacerbations.
Ranjani Somayaji, Jonathan D Cogen, Donald VanDevanter, John J LiPuma, Natalie E West, Patrick A Flume

J Cyst Fibros· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure of a Bronchiectasis and NTM Care Center: a Position Statement by the Bronchiectasis & NTM Association.
Patrick Flume, Wendy Bullington, Lily Christon, Eva Crawford, Alyssa Ditner

Chest· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop report.
Sylvia Szentpetery, Dara Riva, Yair J Blumenfeld, John F Engelhardt, Carmen Luna-Paredes, Patrick A Flume

J Cyst Fibros· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving cystic fibrosis care models in the modulator era.
Isaac Martin, Felix Ratjen, Patrick Flume

Curr Opin Pulm Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exercise Testing in CF-Time to Move On.
Lauren J Sullivan, Patrick A Flume

Arch Bronconeumol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of psychological care into a nontuberculous mycobacteria (NTM) program in the Southeastern United States: A retrospective cohort study.
Lillian M Christon, Wendy Bullington, Lauren Sullivan, Patrick A Flume, Susan Dorman

Ther Adv Respir Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bronchiectasis Treatment Goals, Unmet Needs, and Emerging Therapies: A Podcast.
Patrick A Flume, Diego J Maselli

Pulm Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase IIa, Single-Blind, Placebo-Controlled, Parallel-Group Study to Assess Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Brensocatib in Adults with Cystic Fibrosis.
Michael W Konstan, James J Tolle, Emily DiMango, Patrick A Flume, Helen Usansky

Clin Pharmacokinet· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of tetracyclines for nontuberculous mycobacteria: focus on rapidly growing mycobacteria.
Charles L Daley, Patrick A Flume, Jakko van Ingen, Reeti Khare, Christina M Mingora

Eur Respir Rev· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of dornase alfa on imaging features of bronchiectasis.
Christina M Mingora, Federico Mollica, Daan Caudri, Punitkumar Makani, Harm Tiddens, Patrick A Flume

Res Sq· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Clinical, Psychosocial and Economic Burden of Cystic Fibrosis Lung Disease in the Era of CFTR Modulator Therapy.
Isabelle Fajac, Raksha Jain, Marcus A Mall, Bruce K Rubin, Patrick A Flume

Ann Am Thorac Soc· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making real progress in the world of bronchiectasis.
Patrick A Flume, Eva Polverino

J Thorac Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis.
Natalie E West, Michael W Konstan, Patrick A Flume, Donald R VanDevanter, Amalia Magaret

J Cyst Fibros· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial Conduct, Baseline Characteristics, and Symptom Burden of Patients in the ARISE Study.
Charles L Daley, James D Chalmers, Patrick A Flume, David E Griffith, Naoki Hasegawa

Pulm Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Aging Patient with Cystic Fibrosis.
Lauren J Sullivan, Christina M Mingora, Patrick A Flume

Drugs Aging· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between culture conversion and clinical outcomes in nontuberculous mycobacterial pulmonary disease: Narrative review.
Kevin L Winthrop, Christina M Mingora, Cara D Varley, Susan E Dorman, Patrick A Flume

Respir Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roles of immunoglobulin GM and KM allotypes and Fcγ receptor 2 A genotypes in humoral immunity to a conserved microbial polysaccharide in pulmonary diseases.
Janardan P Pandey, Paul J Nietert, Aryan M Namboodiri, Christine Kimball, Patrick A Flume

Genes Immun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Maternal Outcomes During and After Pregnancy.
Raksha Jain, Giselle Peng, MinJae Lee, Ashley Keller, Sophia Cosmich, Patrick A Flume

Chest· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting neutrophil serine proteases in bronchiectasis.
James D Chalmers, Marcus A Mall, Sanjay H Chotirmall, Anne E O'Donnell, Patrick A Flume

Eur Respir J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis.
Matthew N Hurley, Sherie Smith, Patrick Flume, Nikki Jahnke, Andrew P Prayle

Cochrane Database Syst Rev· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adapting the cystic fibrosis care model: Perspectives from people with CF, caregivers, and members of CF care teams.
Quynh T Tran, Enid Aliaj, Murrey G Olmsted, Sarah E Hempstead, Paula H Lomas, Patrick A Flume

J Cyst Fibros· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystic fibrosis foundation position paper: Redefining the cystic fibrosis care team.
Rebekah F Brown, Charlotte T Close, Molly G Mailes, Luis J Gonzalez, Danielle M Goetz, Patrick A Flume

J Cyst Fibros· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Staying agile: Adapting care to meet changing healthcare needs of people with cystic fibrosis.
Rebekah F Brown, A Whitney Brown, Paula Lomas, Quynh T Tran, Sarah E Hempstead, Patrick A Flume

J Cyst Fibros· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis